Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27016260 | 0.97 | ALDH1A1 (0.36) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL20156220 | 0.97 | ALDH1A1 (0.40) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL26041600 | 0.95 | NR3C1 (0.39) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL26041596 | 0.95 | ABCG2 (0.41) | ABCG2ABCB1PGRPIK3CDPIK3CA | |
| SCHEMBL20155977 | 0.94 | ALDH1A1 (0.38) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL23464421 | 0.93 | ALDH1A1 (0.43) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL26054325 | 0.92 | NR3C1 (0.39) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL27016254 | 0.92 | CYP1A2 (0.39) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL26057456 | 0.92 | NR3C1 (0.38) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL27016258 | 0.92 | ALDH1A1 (0.39) | ALDH1A1LMNAHPGDMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018127-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240018127-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018127-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, ORC3, ORAI3 | ALDH1A1 1566/4885LMNA 3414/4885HPGD 4047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.